Center for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington ,District of Columbia20375, United States.
American Society for Engineering Education, Washington ,District of Columbia20036, United States.
ACS Sens. 2024 Jan 26;9(1):157-170. doi: 10.1021/acssensors.3c01812. Epub 2023 Dec 31.
Almost all pathogens, whether viral or bacterial, utilize key proteolytic steps in their pathogenesis. The ability to detect a pathogen's genomic material along with its proteolytic activity represents one approach to identifying the pathogen and providing initial evidence of its viability. Here, we report on a prototype biosensor design assembled around a single semiconductor quantum dot (QD) scaffold that is capable of detecting both nucleic acid sequences and proteolytic activity by using orthogonal energy transfer (ET) processes. The sensor consists of a central QD assembled via peptidyl-PNA linkers with multiple DNA sequences that encode complements to genomic sequences originating from the Ebola, Influenza, and COVID-19 viruses, which we use as surrogate targets. These are hybridized to complement strands labeled with a terbium (Tb) chelate, AlexaFluor647 (AF647), and Cy5.5 dyes, giving rise to two potential FRET cascades: the first includes Tb → QD → AF647 → Cy5.5 (→ = ET step), which is detected in a time-gated modality, and QD → AF647 → Cy5.5, which is detected from direct excitation. The labeled DNA-displaying QD construct is then further assembled with a Ru-modified peptide, which quenches QD photoluminescence by charge transfer and is recognized by a protease to yield the full biosensor. Each of the labeled DNAs and peptides can be ratiometrically assembled to the QD in a controllable manner to tune each of the ET pathways. Addition of a given target DNA displaces its labeled complement on the QD, disrupting that FRET channel, while protease addition disrupts charge transfer quenching of the central QD scaffold and boosts its photoluminescence and FRET relay capabilities. Along with characterizing the ET pathways and verifying biosensing in both individual and multiplexed formats, we also demonstrate the ability of this construct to function in molecular logic and perform Boolean operations; this highlights the construct's ability to discriminate and transduce signals between different inputs or pathogens. The potential application space for such a sensor device is discussed.
几乎所有的病原体,无论是病毒还是细菌,在其发病机制中都利用关键的蛋白水解步骤。能够检测病原体的基因组物质及其蛋白水解活性是识别病原体并提供其生存能力初步证据的一种方法。在这里,我们报告了一种基于单个半导体量子点 (QD) 支架的原型生物传感器设计,该设计能够通过使用正交能量转移 (ET) 过程同时检测核酸序列和蛋白水解活性。该传感器由通过肽-PNA 接头组装的中央 QD 组成,带有多个 DNA 序列,这些序列编码源自埃博拉病毒、流感病毒和 COVID-19 病毒的基因组序列的互补序列,我们将其用作替代靶标。这些与用铽 (Tb) 螯合物、AlexaFluor647 (AF647) 和 Cy5.5 标记的互补链杂交,产生两个潜在的 FRET 级联:第一个包括 Tb → QD → AF647 → Cy5.5(→ = ET 步骤),这是在时间门控模式下检测到的,而 QD → AF647 → Cy5.5 则是从直接激发检测到的。然后,带有标记的 DNA 展示 QD 构建体进一步与 Ru 修饰的肽组装,该肽通过电荷转移猝灭 QD 光致发光,并被蛋白酶识别以产生完整的生物传感器。每个标记的 DNA 和肽都可以以可控的方式与 QD 进行比率组装,以调整每个 ET 途径。加入给定的靶 DNA 会取代 QD 上标记的互补物,从而破坏该 FRET 通道,而加入蛋白酶会破坏中央 QD 支架的电荷转移猝灭并增强其光致发光和 FRET 中继能力。除了表征 ET 途径并在单个和多重格式中验证生物传感外,我们还证明了该构建体在分子逻辑中执行布尔操作的能力;这突出了该构建体在不同输入或病原体之间区分和转换信号的能力。讨论了这种传感器设备的潜在应用空间。